Glenn R Pilkington
Director of Clinical Development
NEUCLONE
NeuClone
Australia
Biography
Glenn has 20 years of biotech industry experience, with approximately 15 years at management level. His first 11 years were spent in the USA biotech industry, at Intracel Corporation and GlaxoSmithKline spinout, diaDexus LLC. During this time he collaborated successfully with scientists at Thomas Jefferson University, NIH, CDC, California Department of Health and Baylor College of Medicine. Since that time he has worked in management roles at Apollo Life Sciences and Biosceptre International, in the Sydney area, developing therapeutic protein based products, to Phase I and II stage. At Intracel Glenn established a laboratory for discovery of fully human monoclonal antibody products against infectious diseases (RSV, HIV, CMV, hepatitis A, B & C), inflammatory diseases (anti-huCD4) and human tumor associated antigens (huCD20 & colon cancer).
Research Interest
Molecular Biology and Molecular Genetics
